Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Rowe

Showing results (311-320 of 459) with videos related to

Pageof 46
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 20, 2020
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's DiseaseSamuel Shribman, Carolin Heller, Maggie Burrows, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 7, 2021
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementiaAlberto Benussi, Antonella Alberici, Kiran Samra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2020
Clinical Conditions "Suggestive of Progressive Supranuclear Palsy"-Diagnostic PerformanceMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Science Translational Medicine|August 17, 2022
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's diseaseAshwin V Venkataraman, Ayla Mansur, Gaia Rizzo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 15, 2018
In vivo coupling of tau pathology and cortical thinning in Alzheimer's diseaseElijah Mak, Richard A I Bethlehem, Rafael Romero-Garcia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersAlexandra Krugliak, Mats Wj van Es, Marlou N Perquin, et al.
BMJ Open|March 25, 2019
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's diseaseIvan Koychev, Jennifer Lawson, Tharani Chessell, et al.
Brain : a Journal of Neurology|January 27, 2017
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsyLuca Passamonti, Patricia Vázquez Rodríguez, Young T Hong, et al.
The Lancet. Neurology|December 20, 2020
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association studyEdwin Jabbari, Shunsuke Koga, Rebecca R Valentino, et al.
Eclinicalmedicine|May 4, 2022
Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohortAdam Hampshire, Doris A Chatfield, Anne Manktelow MPhil, et al.
Pageof 46

Showing results (311-320 of 459) with videos related to

Sort By:
Pageof 46
Movement Disorders : Official Journal of the Movement Disorder Society|October 20, 2020
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's DiseaseSamuel Shribman, Carolin Heller, Maggie Burrows, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 7, 2021
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementiaAlberto Benussi, Antonella Alberici, Kiran Samra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2020
Clinical Conditions "Suggestive of Progressive Supranuclear Palsy"-Diagnostic PerformanceMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Science Translational Medicine|August 17, 2022
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's diseaseAshwin V Venkataraman, Ayla Mansur, Gaia Rizzo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 15, 2018
In vivo coupling of tau pathology and cortical thinning in Alzheimer's diseaseElijah Mak, Richard A I Bethlehem, Rafael Romero-Garcia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersAlexandra Krugliak, Mats Wj van Es, Marlou N Perquin, et al.
BMJ Open|March 25, 2019
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's diseaseIvan Koychev, Jennifer Lawson, Tharani Chessell, et al.
Brain : a Journal of Neurology|January 27, 2017
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsyLuca Passamonti, Patricia Vázquez Rodríguez, Young T Hong, et al.
The Lancet. Neurology|December 20, 2020
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association studyEdwin Jabbari, Shunsuke Koga, Rebecca R Valentino, et al.
Eclinicalmedicine|May 4, 2022
Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohortAdam Hampshire, Doris A Chatfield, Anne Manktelow MPhil, et al.
Pageof 46